Preclinical mouse models for cancer chemoprevention studies

M Lipkin1, K Yang, W Edelmann

  • 1Strang Cancer Research Laboratory, Rockefeller University, New York, New York 10021, USA. lipkin@rockvax.rockefeller.edu

Insights

New preclinical rodent models help identify chemopreventive agents. These models analyze genetic and environmental factors in tumor development, aiding clinical studies on nutrients and drugs.

Area of Science:

  • Oncology
  • Pharmacology
  • Genetics

Background:

  • Identifying effective chemopreventive agents is crucial for cancer prevention.
  • Traditional models may not fully capture complex tumor development pathways.
  • Novel preclinical models are needed to evaluate cancer-inhibiting compounds.

Purpose of the Study:

  • To introduce and describe new preclinical in vivo rodent models for studying chemoprevention.
  • To highlight the utility of these models in analyzing factors influencing neoplasia.
  • To support the evaluation of chemopreventive efficacy of nutrients and pharmacological agents.

Main Methods:

  • Development of novel in vivo rodent models.
  • Utilizing models with targeted mutations to increase neoplastic lesions.
  • Employing models where dietary nutrients induce preneoplastic lesions in normal mice.

Main Results:

  • These models facilitate the analysis of genetic factors in tumor development.
  • Environmental factors contributing to neoplasia can be studied.
  • The models aid in assessing the efficacy of potential chemopreventive agents.

Conclusions:

  • New preclinical rodent models offer valuable tools for cancer research.
  • These models enhance the understanding of neoplasia development.
  • They support the clinical evaluation of chemopreventive strategies.